ITEM 8.01 OTHER EVENTS.

On February 3, 2021, Pulse Biosciences, Inc. issued a press release announcing U.S. Food and Drug Administration clearance for use of its CellFX? System for dermatologic procedures requiring ablation and resurfacing of the skin.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS



            (d)  Exhibits.

Exhibit No.     Description
  99.1          Press Release issued by Pulse Biosciences, Inc. dated February 3, 2021.
104             Cover Page Interactive Data File (embedded within the Inline XBRL document)



?

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses